ESR1 and breast carcinoma: However, it has been reported that tumor cells from buds do not differ from those belonging to the tumor mass with regard to their both biological and therapeutic target factors in breast cancer, such as ER or HER-2 status [33], and even show a lower Ki67 index compared to those from the tumor mass [15].